Collegiate studies definition

Collegiate studies means a formal program or course of
Sample 1Sample 2Sample 3
Collegiate studies means a formal program or course of study at an institution of higher education leading to the award of academic credit.
Sample 1Sample 2Sample 3

Examples of Collegiate studies in a sentence

  • Collegiate studies listed on resume and/or enlisted/Soldier Record Brief (ERB/SRB), must be documented on transcripts that bear the official stamp/seal of the institution.

  • Locations vary, but in the past they have operated in England, Ireland,Undergraduate programs : Collegiate studies program‌ France, Germany, Italy, Spain, the Middle East, Colombia, Guatemala, Mexico and Perú.

  • Collegiate studies listed on resume and individual’s Soldier Talent Profile (STP), must be documented on transcripts that bear the official stamp/seal of the institution.

Related to Collegiate studies

  • Phase I Clinical Trial means the first study of a Product in humans the primary purpose of which is the determination of safety and which may include the determination of pharmacokinetic and/or pharmacodynamic profiles in healthy individuals or patients.

  • Clinical Trial means any human clinical trial of a Product.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.